As of 27 Apr 2026, Fabino Enterprises is loss-making on a trailing 12-month basis, with a net loss of ₹0.56 Cr, so it has no P/E ratio. The share price is ₹20.31, 25% below its 52-week high. Sales grew 84% a year over 3 years. Debt is 0.45× equity. It is a small-cap company with a market cap of ₹4.27 Cr; the shares fell 12% over the past year.
- ₹20.31
- ₹20.31
- ₹20.31
- ₹20.31
- 18K
Health check
- ReturnsWeak
−11.7% over the past year.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +83.7% a year over 3 years, but loss-making now.
- ProfitabilityNegative
ROCE -11.5%.
- Balance sheetStretched
Debt 0.45× equity, operating profit doesn’t cover interest.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹4.27 Cr
- Small cap
- P/E
- n/a
- Price to book
- 1.17
- Book value ₹17.36
- Dividend yield
- 0.00%
- ROE
- −14.2%
- Return on equity
- ROCE
- −11.5%
- Return on capital employed
- Debt to equity
- 0.45
- Debt ₹1.62 Cr
- EPS (TTM)
- −₹0.73
- OPM (TTM)
- −9.5%
- Net margin −2.7%
- Sales growth
- +3.1%
- Latest quarter vs a year ago
- Profit growth
- −1222.9%
- Latest quarter vs a year ago
- Price to sales
- 0.20
- EV/EBITDA −4.3
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −14.2%.
- Quarterly profit down 1222.9% on a year ago.
- Interest coverage of only −10.1×.
About Fabino Enterprises
Fabino Enterprises Limited manufactures, markets, trades, and packages pharmaceutical and other wellness-focused consumer products in India. It offers tablets, ointments, syrups, and other formulations for various medical treatments in allopathic and certain herbal categories as well as shampoo and hair-maintenance products under Keepshine brand names. The company also exports wellness and FMCG products, such as coffee, malt powder, protein powder, and…
- Headquarters
- Sonipat
- Employees
- 3
- Sector
- Healthcare
- ISIN
- INE0DRT01018
- Website
- fabinolife.com
Price range
- Avg volume (3M)
- 0
- 1-year return
- minus 11.7%
- From 52-week high
- minus 24.8%
Peers
We couldn’t find listed peers for this company.
Quarterly results
| ₹ Cr | Mar 25 | Mar 26 |
|---|---|---|
| 13.8 | 14.2 | |
| 13.7 | 16 | |
| 0.1 | −1.7 | |
| 0.5% | −12.3% | |
| 0.2 | 1.3 | |
| 0.1 | 0 | |
| 0 | 0.1 | |
| 0.2 | −0.6 | |
| 73.5% | 32.5% | |
| 0 | −0.4 | |
| 0.16 | -1.78 |
Profit & loss
- Sales CAGR 3Y
- +83.7%
- ROE
- −14.2%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3.4 | 21.1 | 18 | 20.8 | |
| – | +527.4% | minus 14.5% | +15.6% | |
| 3.3 | 21 | 17.9 | 22.2 | |
| 0 | 0.1 | 0.1 | −1.3 | |
| 1.4% | 0.5% | 0.8% | −6.4% | |
| 0 | 0.1 | 0.3 | 1.6 | |
| 0 | 0 | 0.1 | 0.1 | |
| 0 | 0 | 0.1 | 0.1 | |
| −0 | −0.1 | −0.1 | −0.7 | |
| 0 | 0 | 0.2 | −0.7 | |
| 10.8% | 27.8% | 67.5% | 24.2% | |
| 0 | 0 | 0.1 | −0.6 | |
| – | +231.5% | +70.7% | minus 1014.4% | |
| 0.05 | 0.17 | 0.29 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 2.1 | 2.1 | 2.1 | 2.1 | |
| 2 | 2 | 2.1 | 1.5 | |
| 0.4 | 1.3 | 1.8 | 1.6 | |
| 0.5 | 9.9 | 11.7 | 16.9 | |
| 5 | 15.4 | 17.7 | 22.1 | |
| 0.1 | 0.3 | 0.6 | 0.4 | |
| 0.2 | 0.1 | 0.2 | 0.2 | |
| 4.6 | 15 | 16.9 | 21.6 | |
| 5 | 15.4 | 17.7 | 22.1 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −0.7 | −0.8 | 0.1 | 0.2 | |
| −0 | −0.3 | −0.3 | 0.1 | |
| 0.3 | 0.9 | 0.4 | −0.3 | |
| −0.3 | −0.2 | 0.2 | −0 | |
| −0 | −0.2 | −0.3 | −0 | |
| −0.7 | −1 | −0.2 | 0.2 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.